Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aggressive Seropositive Rheumatoid Arthritis With Diffuse Osteolytic Bone Lesions, Hypercalcemia, and Lymphadenopathy Masquerading as Hematologic Malignancy: A Case Report.

Journal of investigative medicine high impact case reports·2026
Same author

Idiopathic Granulomatous Mastitis Presenting as Refractory Inflammatory Breast Disease in a Young Woman.

Arthritis care & research·2026
Same author

Crowned Dens Syndrome Mimicking Atlantoaxial Infection in a Patient With Systemic Sclerosis: A Case Report.

Case reports in rheumatology·2026
Same author

Management of Hepatic Sarcoidosis: A Retrospective Analysis of Patients at a University Hospital.

Mediterranean journal of rheumatology·2025
Same author

A Conundrum in Coexistence.

Arthritis care & research·2025
Same author

Unveiling the Shadow: Unraveling the Cause of Blindness.

Arthritis care & research·2024

Related Experiment Videos

Wegener granulomatosis: a case report and update.

Eisha Mubashir1, M Mubashir Ahmed, Samina Hayat

  • 1Center of Excellence for Arthritis and Rheumatology, Section of Rheumatology, Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA.

Southern Medical Journal
|September 29, 2006
PubMed
Summary

Wegener granulomatosis (WG) is a rare systemic vasculitis affecting airways, lungs, and kidneys. Early diagnosis and treatment with cyclophosphamide and prednisone significantly improve outcomes, though toxicities necessitate careful management.

Related Experiment Videos

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Pathology

Background:

  • Wegener granulomatosis (WG) is a systemic necrotizing vasculitis of unknown cause.
  • It classically affects the upper airways, lungs, and kidneys, presenting with diverse symptoms.
  • WG has a high mortality rate without treatment.

Observation:

  • A 63-year-old male presented with headaches, eye redness, epistaxis, hemoptysis, and weight loss.
  • These symptoms are consistent with WG's multisystemic nature.
  • The case highlights the varied presentations of this rare disease.

Findings:

  • WG is characterized by granulomatous inflammation and vasculitis.
  • Glucocorticoids and cyclophosphamide induce remission in most patients.
  • Current treatment involves induction with cyclophosphamide followed by less toxic agents like methotrexate.

Implications:

  • Early suspicion and diagnosis of WG are crucial for effective management.
  • Treatment strategies aim to induce remission while minimizing drug toxicities.
  • Understanding WG's varied presentations is vital for internists managing complex cases.